ACQUIRED PERFORATING DERMATOSIS

ACQUIRED PERFORATING DERMATOSIS was reported 16 times

ACQUIRED PERFORATING DERMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMIVANTAMAB-VMJW 1 0.0003
1 CABOZANTINIB 4 0.0001
2 ATEZOLIZUMAB 2 0.0001
3 CETUXIMAB 1 0.0000
4 PEMETREXED DISODIUM 1 0.0000
5 BEVACIZUMAB 3 0.0000
6 IPILIMUMAB 1 0.0000
7 ADALIMUMAB-FKJP 1 0.0000
8 ADALIMUMAB-AATY 1 0.0000
9 GEMCITABINE HYDROCHLORIDE 1 0.0000
10 ADALIMUMAB-ADAZ 1 0.0000
11 CISPLATIN 1 0.0000
12 NIVOLUMAB 1 0.0000
13 METFORMIN ER 500 MG 3 0.0000
14 PACLITAXEL 1 0.0000
15 PEMBROLIZUMAB 1 0.0000
16 CYCLOSPORINE 1 0.0000
17 CARBOPLATIN 1 0.0000
18 PREDNISOLONE ORAL SOLUTION 1 0.0000
19 METHOTREXATE SODIUM 1 0.0000
20 ETANERCEPT 1 0.0000
21 ADALIMUMAB 1 0.0000